Jul 31, 2025

Year in Review: Clinical Investigator Perspectives on the Most Relevant New Datasets and Advances in Gynecologic Cancers | Faculty Presentation 1: Ovarian Cancer — Ursula Matulonis, MD

CME information and select publications

Jul 30, 2025

Featuring an interview with Ms Kathleen D Burns, including the following topics:

• Case: A man in his early 70s with metastatic hormone-sensitive prostate cancer who received an androgen receptor inhibitor in combination with androgen deprivation therapy (0:00)
• Case: A man in his early 70s with...

Jul 29, 2025

Featuring an interview with Dr Hope S Rugo, including the following topics:

• Pharmacologic features of antibody-drug conjugates (ADCs) and implications for their efficacy and toxicity in HR-positive breast cancer (0:00)
• Clinical and biological factors influencing the sequencing of approved ADCs for HR-positive and...

Jul 28, 2025

Featuring a slide presentation and related discussion from Dr Hope S Rugo, including the following topics:

• Current treatment landscape for and outcomes in HR-positive, HER2-negative metastatic breast cancer (mBC) (0:00)
• Trastuzumab deruxtecan for HER2-low and HER2-ultralow mBC (7:49)
• Sacituzumab govitecan for...

Jul 24, 2025

Featuring perspectives from Dr Rashmi Chugh and Dr Mrinal Gounder, including the following topics:

• Introduction: Current Role of General Medical Oncologists in the Treatment of Soft Tissue Sarcomas (STS) (0:00)
• Incorporation of Novel Agents and Strategies into the Management of STS — Faculty Presentation...